Dairy Product Safety on the Agenda

Ensuring food safety and raising consumer confidence has been the central preoccupation of the whole dairy industry this year. In this context, the 19th annual meeting of the China Dairy Industry Association (CDIA) was held on 13-15 September in Fuzhou, Fujian province, with the theme of safety, responsibility, reputation, according to Dairy Products China News 1310 issued by CCM.

 

Due to the efforts made by the Chinese government and the dairy processors,the dairy industry has continued in its recovery with slight growth. According to the data from the National Bureau of Statistics, dairy output reached 13.1 million tonnes in H1 2013, with a YoY growth of 11.6%. From this figure, liquid milk/yoghurt and milk powder/formula reached 11.3 million tonnes and 0.8 million tonnes, up 12.4% and 5.9%respectively year on year. Meanwhile,the dairy industry recorded a net profit of USD1.4 billion (RMB8.7 billion) in H1 2013, up 23.6% YoY.

 

However, consumer confidence in domestic dairy products is far from restored, which can be reflected by a number of data. China imported 91,500 tonnes of infant formula (in retail packaging) in 2012, up 16.9% over 2011, while it imported 56,000 tonnes in H1 2013, an increase of 28.5%.Imports of liquid milk increased from 40,500 tonnes in 2011 to 93,800 tonnes in 2012 and then rose to 96,000 tonnes in H1 2013, up 152% over H1 2012. Moreover, all these figures exclude the volumes coming in directly as a result of consumers’ overseas purchases.

 

Additionally, the dairy industry continues to face insufficient milk supply. This has been underlined with the shortages in availability of domestic liquid milk in some cities since early September (this has been seen in diverse locations including Guangzhou, Shenzhen and Jinan). The shortage stems from falling cow numbers in key milk production areas as household producers have been exiting the market, leaving the large-scale dairy farms unable to keep pace with demand. The interrupted supply of milk powder from New Zealand has also played a part here of course. It appears likely that some companies will aim to safeguard their profitability by decreasing production of mid-market and low-end liquid milks in order to maintain output of premium products.

Promoting the safety and quality of dairy products is still the key task for the Chinese government. According to Mr. Ma Chunliang, Deputy Director of China Food and Drug Administration(CFDA), the Detailed Rules for Infant Formula Processor Approval will be released soon: this is in review phase,with 10,000+ opinions submitted from the public on its topics (please see Dairy Products China News Vol.6 September Issue, p8). The CFDA is now formulating other policies and measures, such as regulations controlling infant formula sales in pharmacies, labelling and packaging for infant formula, plus a system recording production information on the infant formula processors.

 

By the end of June, 917 dairy processors had received production licenses compared with 716 at the end of 2011. From the latest figure 128 are infant formula processors, compared with 119 at the end of 2011. Mr. Song Kungang, the CDIA’s Director, noted that China’s dairy industry has entered into an adjustment and refinement stage, and especially the infant formula industry will face consolidation as a number of dairy processors will be eliminated in the near future. (Note: some earlier figures put out on the total number of processors were lower due to the exclusion of small scale dairy companies). The changes on pharmacy sales are important when it is considered that dairy products sell at an estimated 2.1 million individual points of sale (that is retail stores of all types) around the country as against infant formula selling through just 500,000.

 

Mr. Zhu Hongren, chief engineer of the Ministry of Industry and Information Technology (MIIT), indicated that the acquisition and reorganization of the dairy industry will be promoted by both market mechanisms and government guidance. The key factors of production– inputs to the production process, including land, capital, information, etc – will be concentrated amongst the leading companies upon which the government will focus its support and also its pressure to upgrade. In addition, large-scale companies are encouraged to merge and reform small-scale companies; middle and small scale companies are encouraged to merge and set up industrial alliances; moreover MIIT is also encouraging competitive and listed companies to put in place international business strategies.

 

It’s worth noting that the China Chamber of Commerce of Foodstuffs and Native Produce (CCCFNP) established a dairy product imports working group on 11 September, part of the Chinese government’s move to ensure the safety of imported dairy products. This working group will specialise in solving the problems faced by the growing number of dairy product importers – currently, 1400+ import agents of dairy products have been recorded by the CCCFNP.

Table of Contents of Dairy Products China News 1310:

Key Processors’ Performance in H1

Dairy Product Safety on the Agenda

Dumex Caught in Bribery Scandal

Government Further Promotes Infant Formula Consolidation

Hebei Promotes Milk Powder/Formula Industry Development

Huishan Dairy IPO and Listing

Beijing Sanyuan to Expand Formula Business

Shengmu Farming Plans for Organic Growth

Tianyou Dairy Targets Infant Formula

Modern Dairy Performs Well in 2013

Yinqiao Biotech Launches New Fresh Milk

Treasure of Plateau Launches Yak Milk Infant Formula

Dairy Products China News, a monthly publication issued by CCM on 15^th, offers you the latest information on new market dynamics, company development, new products, technology, packaging and raw material supply, etc. It also focuses on the government’s direction and polices, helping you get the whole picture of the industry. 

About CCM

CCM is dedicated to market research in China, Asia-Pacific Rim and global market. With a staff of more than 150 dedicated highly-educated professionals, CCM offers Market Data, Analysis, Reports, Newsletters, Buyer-Trader Information, Import/Export Analysis, and Consultancy Service. 

For more information, please visit http://www.cnchemicals.com.

Guangzhou CCM Information Science & Technology Co., Ltd.
17th Floor, Huihua Commercial & Trade Mansion, No.80 Xianlie Zhong Road, Guangzhou 510070, China

Tel: 86-20-37616606

Email: econtact@cnchemicals.com

Draft Rules for Infant Formula Processors Launched

According to Dairy Products China News 1309 issued by CCM, on 2 August, the China Food and Drug Administration (CFDA) issued the draft revised version of the proposed Detailed Rules for Infant Formula Processor Approval for 2013 to solicit opinions from the dairy industry and the public (the previous version was issued by the General Administration of Quality Supervision, Inspection and Quarantine and took effect from 1 November 2010). The period for receiving comment on the revised draft lasted for 13 days and closed on 15 August. Compared with the old version, the new draft is more specific and includes some new regulations, aiming to increase the requirements for infant formula processors in production and management aspects. Some new regulations are notable:

• Food safety management. Processors are required to implement Hazard Analysis Critical Control Point (HACCP) and Good Manufacturing Practice (GMP) systems. Companies are required to set up a quality and safety management department, with full-time managers responsible for the establishment, implementation and improvement of the company’s food safety and quality system

• Raw materials. Processors using raw milk are required to build their own dairy farms, while those using milk powder are required to have a clear, defined and controlled milk source (whether through building their own farms, cooperating with other companies or having firm contractual relationships in place with producers); water supply for processing and cleaning should be purified to meet the quality standards in the Pharmacopoeia of China; processors must make a safety and quality assessment of their raw material suppliers and sign a quality assurance agreement with them, in which both sides must take on responsibility for quality

• R&D capability. Processors should establish an R&D department capable of developing new infant formula products, determining the products’ shelf life, researching potential risk factors in the production process and taking corresponding measures. The department should have no less than 5 researchers, including at least 2 senior engineers or holders of a master’s degree

• Information management. A searchable system should be established to provide information on labelling, packaging, quality standards and factory inspection report for consumers; processors must record data on their operations from raw material procurement through to product sales in order to establish a complete product traceability system

• Storage and distribution. The storage area should have enough space to house all goods in an orderly fashion, including raw materials, finished products, packing materials etc; the warehouse should be able to protect the goods from the effects of the climate; the company should complete data records on materials circulation

In addition to the above aspects, some other regulations are more specific and stricter compared with the old version. For example, in terms of production facilities, the requirements include cleanliness of the production environment, required production equipment and detection equipment, etc. More pieces of equipment are required than before: 13 dry blenders are required instead of 6, for instance, with stricter requirements for these items. This implies processors will need to buy more equipment, so impacting their production costs.

The core objective of the new document is to strengthen management in the infant formula sector and ensure the quality and safety of products, signifying the Chinese government’s determination to promote the development of the local infant formula industry. In line with the requirement for sector consolidation, it will prove much easier for large-scale processors to meet the new requirements in areas such as GMP and R&D than for some small scale processors, which may even lack a technician. Processors are expecting the authorities to provide more details; there is a general expectation that about half of the small scale processors may be eliminated from the dairy market, and more strict regulations will follow.

On the same day (2 August), CFDA issued a list of 128 domestic companies that are qualified for producing infant formula. The list will assist the public to readily identify the producers as a basis for assessing their qualifications and credentials. CFDA said that it will launch a campaign to examine and record information on the infant formula processors as part of its efforts to clean up the industry and standardise product information, and detailed information on the infant formula producers and their products will be published after this campaign. It indicated that some small players are expected to be eliminated in this manner.

Table of Contents of Dairy Products China News 1309:

Dairy Industry Progress in Q2

BCA Releases Infant Formula Quality Comparison Report

Infant Formula Sales to Roll Out at Pharmacies

Infant Formula Processors Show Growth in H1

Bacteria Crisis Shakes Chinese Customers’ Confidence

Draft Rules for Infant Formula Processors Launched

Government Promotes Dairy Industry Development

Beijing Sanyuan Continues Integration

Xiyuchun Dairy to Enter Infant Formula Market

Rapid Development of Raw Milk Supply in Heilongjiang 

Raw Milk Price Rises

Aohua Food Launches Almond Protein Milk

Dairy Products China News, a monthly publication issued by CCM on 15^th, offers you the latest information on new market dynamics, company development, new products, technology, packaging and raw material supply, etc. It also focuses on the government’s direction and polices, helping you get the whole picture of the industry. 

About CCM

CCM is dedicated to market research in China, Asia-Pacific Rim and global market. With a staff of more than 150 dedicated highly-educated professionals, CCM offers Market Data, Analysis, Reports, Newsletters, Buyer-Trader Information, Import/Export Analysis, and Consultancy Service. 

For more information, please visit http://www.cnchemicals.com.

Guangzhou CCM Information Science & Technology Co., Ltd.
17th Floor, Huihua Commercial & Trade Mansion, No.80 Xianlie Zhong Road, Guangzhou 510070, China

Tel: 86-20-37616606

Email: econtact@cnchemicals.com

Pharmacy starts trial sales of infant formula

Historically, China’s pharmacies have not sold infant formula. This reflected a regulatory situation in which they needed a Pharmaceutical Trade License from the local Food and Drug Administrations, while retailers selling food required a Food Circulation Permit from local government. Few applied for both, especially as Chinese consumers were accustomed to buying infant formula from supermarkets. Recently, though, some pharmacies have started to sell infant formula in some cities, such as Guangzhou, Shanghai and Qingdao. However, there are still obstacles in the development of this channel.

 

A case in point is LBX Pharmacy, a well known national pharmacy chain, which held an event on 10 July to formally announce that it is focusing on promoting formula sales. The chain has established special counters for infant formula in 3 of its flagship stores in Guangzhou;10 brands of infant formula are sold, including Abbott, Wyeth, Biostime etc. Most of those stocked are multinational brands, but the company intends to introduce more domestic infant formula brands. In fact, LBX Pharmacy began to sell infant formula as long ago as 2009 in its flagship stores nationwide, although at that stage it sold only one brand –Biostime. Sales through pharmacies accounted for about 8% of Biostime’s total sales in 2012 and Biostime believe this channel will contribute significantly to its business in the future with more government promotion in this sector.

This trend is indeed promoted by government policy. According to Dairy Products China News issued by CCM in August, on 20 June, 9 ministries including the Ministry of Agriculture and the China Food and Drug Administration (CFDA) released Suggestions on Further Strengthening Infant Formula Safety and Quality. One of the measures requires trying out special counter sales of infant formula in pharmacies – this attracted the public’s attention and led to requests for further information about the policy. In this context, the CFDA released further details, indicating that the idea of trying out sales of infant formula in pharmacies is based on the experience from overseas markets, where pharmacies provide a key sales channel for infant formula.

The channel is expected to better guarantee the safety of infant formula because of the strict management system (with Good Supply Practices for Pharmaceutical Products, “GSP”) under which pharmacies operate. The details noted that the CFDA would gradually carry out a pilot program in this sales channel, and that any pharmacy which receives a circulation license for infant formula can set up a special counter in this way. Based on the pilot results, the CFDA would formulate related management measures and supervision systems to refine the approach.

 

Some pharmacies see this as an opportunity given government promotion of the channel and their GSP management, which is stricter than supermarkets, and the presence of nutritionists to provide nutrition services and professional advice to consumers, rather than simply sales staff in supermarkets. However, there are obstacles in promotion of this sales channel.

Customers are still used to buying infant formula through traditional channels in China, especially in supermarkets, so it may be hard for them to change this habit. Supermarkets sometimes run sales promotions on infant formula, which are attractive for customers. In addition, some pharmacies are unwilling to try the new approach; one factor is that, unlike with infant formula, pharmacies typically get discounts of 30-40% on the prices of healthcare products, making them more profitable for them. It’s expected that more regulations will be issued to lay out how formula sales though pharmacies will work in practice.

 

A number of pharmacies are also likely put off because in the past some such chains have tried this channel before and then given it up or ended up struggling to make enough sales. For example, Da Shen Lin Pharmacy, another well known national chain pharmacy, has been selling just 2 brands of infant formula (Mead Johnson and Abbott) in some of its flagship stores since 2010, but with only low sales to date.

Table Contents of Dairy Products China News 1308:

Prospects for Jiyuan Yili Dairy

Infant Formula Prices Decrease

Milk Supply Shortfall Debate

Pharmacy Starts Trial Sales of Infant Formula

Dairy Imports Increase in H1

NZ Starts Infant Formula Brand Register

Government Boosts Livestock Subsidy

Yili Partners with Dairy Farmers of America

Hunan Dakang Targets Dairy Business

Huishan Dairy Expands Farming Activities

Tianyou Dairy Launches New Yoghurt

QHT Performs Well in GOS

Dairy Products China News, a monthly publication issued by CCM on 15^th, offers you the latest information on new market dynamics, company development, new products, technology, packaging and raw material supply, etc. It also focuses on the government’s direction and polices, helping you get the whole picture of the industry. 

About CCM

CCM is dedicated to market research in China, Asia-Pacific Rim and global market. With a staff of more than 150 dedicated highly-educated professionals, CCM offers Market Data, Analysis, Reports, Newsletters, Buyer-Trader Information, Import/Export Analysis, and Consultancy Service. 

For more information, please visit http://www.cnchemicals.com.

Guangzhou CCM Information Science & Technology Co., Ltd.
17th Floor, Huihua Commercial & Trade Mansion, No.80 Xianlie Zhong Road, Guangzhou 510070, China

Tel: 86-20-37616606

Em

Further Government Focus on Infant Formula Standards

According to Dairy Products China News issued by CCM in June, On 4 June, the Ministry of Industry and Information Technology (MIIT) released an Action Plan for Improving the Quality Level of Formula Powder and Enhancing Consumer Confidence (the Plan), aiming to strengthen the competitiveness of domestic infant formula.

The Plan emphasizes several aspects as follows:

• Strengthening internal management procedures: MIIT will organize special inspections to assess the quality and safety of infant formula processors during June- August, aimed at driving them to improve and implement their internal quality and safety management systems, and take measures to improve consumer confidence. For example, they should publicize basic information about their business and make available a contact number for their chief executives on the National Food Industry Enterprise Credit Information Public Service Platform (a website which was launched in September 2011 by the China government to foster greater “integrity” amongst food enterprises). They should also make a public commitment in advertising media that they are working to ensure product quality and safety

• Strengthening management of industry development: the Plan aims to regularize the numerous investments in new plants or in plant refitting/expansion by reviewing these during the year and eliminating projects which are judged to be non-beneficial

• Boosting the industry’s restructure by encouraging M&A to achieve a more concentrated industry which can allocate more funds to R&D, whilst closing down backward production facilities

• Promoting technical renovations of infant formula enterprises to put in place better processes for quality control, safety and health, monitoring and testing of products, and establishing traceability systems

• Improving industrial standards: the government will speed up the formulation or revision of product standards, management and inspection standards, as well as increasing the transparency of the standard formulation process (an aspect which has encouraged no little controversy in the past)

• Strengthening the industry’s public image: in order to increase consumer confidence, infant formula enterprises should organize consumer visits to their plants. The industry association should work to raise awareness of food safety laws and regulations and relevant scientific knowledge, and strengthen the education and training of processors’ staff in terms of professional ethics and know-how

It is estimated that about half of the infant formula brands (both domestic and imported) will be eliminated from the Chinese market, if the Plan is implemented strictly. At present, most Chinese infant formula producers are small-scale. It is reported that overall local sales of infant formula stand at USD9.6 billion/RMB60 billion (USD6.2 billion/RMB38.5 billion in 2012 according to AC Nielsen), and that about USD1.6 billion (RMB10 billion) comprises product from small-scale producers, mostly operating as OEMs. If the Plan succeeds in requiring true traceability systems these products will not survive, opening up the USD1.6 billion (RMB10 billion) segment to national and some 2nd and 3rd tier brands.

However, such a dramatic level of industry restructuring seems ambitious to say the least − what the government wants and what the market provides may prove hard to align. Certainly the Plan represents the continuation of the State Council’s decision making. On 31 May, Chinese Prime Minister Li Keqiang held an executive meeting of the State Council and emphasized that the government will further strengthen the quality and safety supervision of infant formula. This followed the release by the China Dairy Industry Association in April of a report which announced that the quality of domestic infant formula is much higher than that of imported infant formula, while the latter is twice as expensive. Unsurprisingly this prompted a good deal of consumer questioning, as it flew in the face of their perceptions. Whether realistic or not, the Plan does at least set out to address such matters in a more credible fashion.

Table of Contents of Dairy Products China News 1306:

Xinjiang Dairy Expansion Faces Challenges

Dairy Industry Overview, January-April

Further Government Focus on Infant Formula Standards 

Mengniu + Yashili: The Start of China’s Dairy Industry Integration

Mead Johnson Focus On Online Sales

Western Stock Raising Targets Infant Formula Market

Fengxing Dairy Expansion

Yahua Dairy Sets Up JV

Ningbo Dairy Responds to Products Incidents

Chinese Government Supports Milk Production

Mengniu Launches UHT Yoghurt

Bimbosan Introduces Super Premium Formula

Dairy Products China News, a monthly publication issued by CCM on 30^th or 31^st, offers you the latest information on new market dynamics, company development, new products, technology, packaging and raw material supply, etc. It also focuses on the government’s direction and polices, helping you get the whole picture of the industry. 

About CCM

CCM is dedicated to market research in China, Asia-Pacific Rim and global market. With a staff of more than 150 dedicated highly-educated professionals, CCM offers Market Data, Analysis, Reports, Newsletters, Buyer-Trader Information, Import/Export Analysis, and Consultancy Service. 

For more information, please visit http://www.cnchemicals.com.

Guangzhou CCM Information Science & Technology Co., Ltd.
17th Floor, Huihua Commercial & Trade Mansion, No.80 Xianlie Zhong Road, Guangzhou 510070, China

Tel: 86-20-37616606

Email: econtact@cnchemicals.com

Discover Potential Business in Dairy Products China News

The May issue of Dairy Products China News has been come out recently. The latest issue focuses on infant formula market, covering the new giant in this market and restriction of bovine colostrum in infant formula. Besides, new standard for food fortification ingredients is discussed in the May issue as well.

China is, as ever, awash with statistics. According to the National Bureau of Statistics the country’s retail sales climbed 14.1% in April to RMB1.56 trillion ($247.8 billion), the slowest increase in the past 66 months. In real terms this represented a rise of 10.9%. The current price figure was less than the 15.2% increase seen in March 2012 and below general expectation. Urban retail sales of consumer products rose 14% to RMB1.36 trillion ($215.36 bn) year-on-year; rural regions’ sales rose 14.5% to RMB204.9 bn ($32.44bn). Last month’s overall economic data was generally weaker than had been anticipated. One example: sales of residential properties fell 13.5% year on year to RMB1.03 trillion during January-April 2012, and sales of office properties fell 14% to RMB 54.3 billion.

The situation has just prompted the Chinese Government to cut the reserve requirement ratio for local banks from May 18 by 50 bps to 20%. The cut was the 3rd in 6 months and frees up an additional RMB400 billion in the banking system, although China’s major banks have declined, looking for a larger cut.

The market future continues to be the subject of intense debate and has been much discussed at recent dairy industry events – notably at SIAL in Shanghai, ADPI in Chicago and even at the DIN conference in London. Despite the information available it struck us in discussions that a number of the exporters and distributors were surprisingly uninformed on the Chinese dairy marketplace. It’s often easier to strike some deals than consider the bigger issues – and there’s always a danger of information overload – but is this the right market or time for a high risk approach?

Check more details and discover the potential business opportunity in Dairy Products China News, co-published by CCM International and Orrani Consulting.

About CCM International

CCM International is dedicated to market research in China, Asia-Pacific Rim and global market. With a staff of more than 150 dedicated highly-educated professionals. CCM International offers Market Data, Analysis, Reports, Newsletters, Buyer-Trader Information, Import/Export Analysis all through its new proprietary product ValoTracer. For more information, please visit http://www.cnchemicals.com.

CCM International Ltd.
Guangzhou CCM Information Science & Technology Co., Ltd.
17th Floor, Huihua Commercial & Trade Building, No.80 Xianlie Zhong Road, Guangzhou 510070, China

Tel: 86-20-37616606

Email: econtact@cnchemicals.com

Source: http://www.cnchemicals.com/PressRoom/PressRoomDetail_w_1093.html

MOH Forbids the Addition of Bovine Colostrum in Infant Formula

On 16 April the Ministry of Health (MOH) issued a ruling to the General Administration of Quality Supervision, Inspection and Quarantine (GAQSIQ) that bovine colostrum may not be added to 1st/2nd/3rd stage infant formula. This could have a significant impact on the wider colostrum category, which includes a range of formula with colostrum (for babies/infants/adults) along with colostrum powder and colostrum supplements, namely tablets and capsules, according to CCM International’s May issue of Dairy Products China News

By way of illustration, the portfolio of leading player Biolife in China comprises:

Pure colostrum powder – for instance Biolife advertises that these products (notably established brands such as Natrapure and Peizhi/Healtheries and the newer Keymore Bovine Pure Colostrum Powder) exclude any sugar or chemical preservatives and have IgG levels exceeding 10% (10%, 15%, 20%, 25% and 35%), in line with RHB602-2005. These products can be sold in Chinese market in the future. Interestingly these products are often targeted at being given to babies, especially when many parents misunderstand them to be formula powders

Colostrum milk powder, with IgG levels under 10% (Biolife’s “golden pack” ranges under its Natrapure and Peizhi/ Healtheries brands are just 3%). These are not classified as bovine colostrum powder according to RHB602—2005, but simply as colostrum-enriched foods. It appears from the MOH’s ruling that these products can no longer be advertised as colostrum milk powder (although this point is not clear and needs further explanation from MOH)

Colostrum tablets and capsules, which Biolife advertises as functional foods (of which there are 24 approved categories locally); these clearly have IgG levels which are higher than colostrum milk powder and are mainly consumed by adults, not least because in China, many parents won’t let their children eat functional foods. However Biolife recommends its colostrum tablets and capsules for babies which do not chew their food sufficiently!

The statement from the MOH includes 3 items:

Firstly, that the production of bovine colostrum powder should be in accordance with industry standard (RHB602 -2005):so before the launch of the national standard, this industry standard will effectively be treated as such … …

Secondly, if the bovine colostrum is added to ordinary foods, it should meet the related food standards … ….

Thirdly, that formula may not include any dairy ingredients which use bovine colostrum as raw material. This requirement will be effective from 1 September, although products imported or produced before this date may still be sold up to their expiry dates … …

At present, there is no national standard for bovine colostrum products, only the industry standard RHB602-2005 for bovine colostrum powder. This was set up by the China Dairy Industry Association in 2005 with input from Biolife − there is no national standard for bovine colostrum. If a product does not meet the requirements of RHB602-2005, it is considered a functional food. According to RHB602 – 2005, pure colostrum powders should contain at least 40% protein and 10% IgG. So in theory, if the MOH is interpreted literally, many companies have to change their promotional strategies.

The ruling has been explained by some in terms of the minor local output of bovine colostrum, its variable quality and the difficulty involved in its industrial production, with further suggestions that it is unproven for use in formula.

In fact the ruling of the MOH is in accordance with the National Food Safety Standard for Raw Milk, which was issued on 26 March 2010 and implemented on 1 June 2010. According to that standard, bovine colostrum (from the first 7 days) may not be used as raw milk. This led to a lack of clarity and in line with this change, the Guangdong office of GAQSIQ stopped imports of formula powders with colostrum in August 2011 while it awaited clarification of the national standard. Subsequently a distributor from Guangdong made complaints to the press in March 2012 that its residual stocks of such products hadn’t sold out, and this story was widely reported, compelling the MOH to make a response.

It seems that the market for formula products including bovine colostrum – which has grown rapidly and is estimated at about USD317.0 million (RMB2 billion) currently – will be impacted by the official reply.

Source: Dairy Products China News  1205

http://www.cnchemicals.com/Newsletter/NewsletterDetail_22.html

Content of Dairy Products China News 1205:

Key Processors’ Strong Performance in 2011

Key Processors’ Increasing Investment in Marketing in 2011

Domestic Dairy Industry Hurt by Industrial Grade Gelatin?

Interface Protein Cuts Cheese Prices

Infant Formula Processors’ Results Signal Mixed Fortunes

New Standard for Food Fortification Ingredients

MOH Forbids the Addition of Bovine Colostrum in Infant Formula

Nestlé + Wyeth: A New Giant in China’s Infant Formula Market

Bright Dairy Builds Up its Yoghurt Business in Southern China

Henan Government Promotes Local Milk Production

Greatview Packaging Enjoys Good Development in 2011

Taizinai Group Launches New Products

Dairy Products China News, a monthly publication issued by CCM International on the 30th/31st of every month, brings you the latest information on new market dynamics, company dynamics, new dairy products and consumption trend, new legislations and policies and raw milk supply dynamics that are shaping the market.

About CCM International

CCM International is dedicated to market research in China, Asia-Pacific Rim and global market. With a staff of more than 150 dedicated highly-educated professionals. CCM International offers Market Data, Analysis, Reports, Newsletters, Buyer-Trader Information, Import/Export Analysis all through its new proprietary product ValoTracer.

For more information, please visit http://www.cnchemicals.com.

CCM International Ltd.
Guangzhou CCM Information Science & Technology Co., Ltd.
17th Floor, Huihua Commercial & Trade Mansion, No.80 Xianlie Zhong Road, Guangzhou 510070, China

Tel: 86-20-37616606

Email: econtact@cnchemicals.com

Source : http://www.cnchemicals.com/PressRoom/PressRoomDetail_w_1074.html

Booming DHA Docosahexaenoic Acid Market in China

Production and Market of DHA in China has been released by CCM, revealing the DHA market in China is booming in the future.

DHA becomes more and more popular in the recent years. The primary source of DHA is fish oil. However, customers prefer microalgae DHA to fish oil DHA because of high quality and safety of the former since DHA was successfully obtained from microalgae.

The output of microalgae DHA has realized an increase of 443 tonnes at a CAGR of 23% from 2007 to 2010 thanks to the growing demand growth. China's consumption of DHA, both fish oil and microalgae DHA, keeps fast growth at a CAGR of 21% during 2007-2010. This trend will continue in the future, as the demand from downstream industries is keeping increasing.

In spite of the rapid development, the industry stays at an initial development stage compared with that in developed countries. Therefore, there is plenty of space for China's DHA industry to develop. More and more companies are planning to expand production scale or enter the industry attracted by the high profit.

This report provides primary data and analysis about DHA industry in terms of production situation, pricing and consumption in China to help reader gain vital business intelligence of China's DHA market. Based on in-depth investigation, CCM forecasts the supply and demand of DHA in China to 2015.

If you are interested in this report, please click the following link for more information:

http://www.cnchemicals.com/Report/ReportMin_1908.html

(Guangzhou China, August 29, 2011)

About CCM

CCM is dedicated to market research in China, Asia-Pacific Rim and global market. With a staff of more than 150 dedicated highly-educated professionals. CCM offers Market Data, Analysis, Reports, Newsletters, Buyer-Trader Information, Import/Export Analysis all through its new proprietary product ValoTracer.
Please visit http://www.cnchemicals.com for more information or contact econtact@cnchemicals.com

CCM International Ltd.
Guangzhou CCM Information Science & Technology Co., Ltd.
17th Floor, Huihua Commercial & Trade Mansion, No.80 Xianlie Zhong Road, Guangzhou 510070, China

Demand for DHA Docosahexaenoic Acid Products to Be Increasing

Guangzhou China, August 18, 2011 – CCM has launched the brand-new DHA report, entitled Production and Market of DHA in China. It is estimated that the demand for DHA products will be increasing in the future, with the improvement in people's health care consciousness.

This report provides primary data and analysis about DHA industry in terms of production situation, pricing and consumption in China to help reader gain vital business intelligence of China's DHA market.

DHA has attracted more and more attention since it has been recommended by World Health Organization in 1993. China has industrialized DHA production in 2002. Most domestic producers use microalgae as raw material to produce microalgal DHA, which has better quality than fish oil DHA.

China's microalgal DHA industry has seen booming growth in recent years. By July 2011, there are 15 active microalgal DHA producers in China, with total capacity of 1,475t/a. The output has been increased from 503 tonnes in 2007 to 946 tonnes in 2010, thanks to its growing demand in the market.

China's DHA consumption is still limited but has huge potential. In 2010, the total consumption volume of DHA is 2,260 tonnes. Formula foods and health care products are major end-users. Among formula foods, DHA is mainly used in infant formula, infant cereal and maternal formula, and it can also be used in some milk beverages. Cooking oil is an emerging end-use segment in China. The demand for DHA products is expected to be increasing in the future.

If you are interested in this report, please click the following link for more information:

http://www.cnchemicals.com/Report/ReportMin_1908.html

About CCM

CCM is dedicated to market research in China, Asia-Pacific Rim and global market. With a staff of more than 150 dedicated highly-educated professionals. CCM offers Market Data, Analysis, Reports, Newsletters, Buyer-Trader Information, Import/Export Analysis all through its new proprietary product ValoTracer.
Please visit http://www.cnchemicals.com for more information or contact econtact@cnchemicals.com

CCM International Ltd.
Guangzhou CCM Information Science & Technology Co., Ltd.
17th Floor, Huihua Commercial & Trade Mansion, No.80 Xianlie Zhong Road, Guangzhou 510070, China